IRCCS SAN RAFFAELE ROMA SRL
๐ฎ๐นItaly
- Country
- ๐ฎ๐นItaly
- Ownership
- Subsidiary
- Employees
- -
- Market Cap
- -
Clinical Study of Patients Treated With PuraBond Haemostatic Agent During Abdominal Aorta Open Repair
Recruiting
- Conditions
- Hemostatic
- Interventions
- Device: Purabond
- First Posted Date
- 2023-02-17
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- IRCCS San Raffaele
- Target Recruit Count
- 100
- Registration Number
- NCT05733585
- Locations
- ๐ฎ๐น
IRCCS San Raffaele Hospital, Milano, Italy
Retrospective Observational Comparison Study Between Ustekinumab and Tofacitinib as Third Line Therapy in a Multicenter Cohort of Patients With Refractory Ulcerative Colitis.
- First Posted Date
- 2023-02-14
- Last Posted Date
- 2023-02-14
- Lead Sponsor
- IRCCS San Raffaele
- Target Recruit Count
- 100
- Registration Number
- NCT05728008
- Locations
- ๐ฎ๐น
Mariangela Allocca, Milano, Italy
Comparative Accuracy of Transperineal Ultrasound (TPUS) Versus Magnetic Resonance Imaging (MRI) for the Assessment of Perianal Fistulae in Patients With Crohn's Disease (CD): a Prospective Observational Longitudinal Cohort Study
Recruiting
- Conditions
- Perianal FistulaCrohn Disease
- First Posted Date
- 2023-02-10
- Last Posted Date
- 2023-02-10
- Lead Sponsor
- IRCCS San Raffaele
- Target Recruit Count
- 50
- Registration Number
- NCT05721794
- Locations
- ๐ฎ๐น
Mariangela Allocca, Milano, Italy
Quantitative Assessment of Intestinal Motility on Bowel Ultrasound in Patients With Inflammatory Bowel Disease: a Feasibility, Observational, Cross-sectional, Monocentric Study
Recruiting
- Conditions
- Inflammatory Bowel Diseases
- First Posted Date
- 2023-02-09
- Last Posted Date
- 2023-02-09
- Lead Sponsor
- IRCCS San Raffaele
- Target Recruit Count
- 100
- Registration Number
- NCT05719402
- Locations
- ๐ฎ๐น
Mariangela Allocca, Milano, Italy
EFFICACY AND SAFETY OF S.C. INFLIXIMAB IN PATIENTS SWITCHED FROM I.V. FORMULATION OF INFLIXIMAB
Recruiting
- Conditions
- Rheumatologic DiseaseInflammatory Bowel Diseases
- First Posted Date
- 2023-02-09
- Last Posted Date
- 2023-02-09
- Lead Sponsor
- IRCCS San Raffaele
- Target Recruit Count
- 250
- Registration Number
- NCT05719389
- Locations
- ๐ฎ๐น
Irccs Ospedale San Raffaele, Milano, Italy
Liver Embolization Approaches for Tumor Management
Recruiting
- Conditions
- CholangiocarcinomaMetastatic CancerMetastatic Gastric CancerMetastatic Colon CancerPrimary Liver CancerMetastatic Pancreatic CancerHepatocellular Carcinoma
- First Posted Date
- 2023-02-06
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- IRCCS San Raffaele
- Target Recruit Count
- 580
- Registration Number
- NCT05714124
- Locations
- ๐ฎ๐น
IRCCS Ospedale San Raffaele, Milan, Italy
Role of the Host Microbiota and Il-17 in Favoring Multiple Myeloma Progression
Completed
- Conditions
- Multiple Myeloma
- First Posted Date
- 2023-02-06
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- IRCCS San Raffaele
- Target Recruit Count
- 62
- Registration Number
- NCT05712967
- Locations
- ๐ฎ๐น
IRCCS Ospedale San Raffaele, Milan, Milano, Italy
Radiology Registry on Pancreatic Malignancies
Recruiting
- Conditions
- Pancreas CystPancreatic CancerPancreas NeoplasmPancreas Disease
- First Posted Date
- 2023-02-06
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- IRCCS San Raffaele
- Target Recruit Count
- 1300
- Registration Number
- NCT05714111
- Locations
- ๐ฎ๐น
Department of Radiology, IRCCS Ospedale San Raffaele, Milan, Italy
Home-based Action Observation Treatment With Virtual-reality for Arm Rehabilitation in People With Multiple Sclerosis
Not Applicable
Recruiting
- Conditions
- Multiple Sclerosis
- Interventions
- Other: Home-based Action Observation Treatment with virtual-reality for upper limb rehabilitationOther: Home-based landscape observation with virtual-reality for upper limb rehabilitation
- First Posted Date
- 2023-02-06
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- IRCCS San Raffaele
- Target Recruit Count
- 60
- Registration Number
- NCT05713890
- Locations
- ๐ฎ๐น
IRCCS San Raffaele, Milan, Italy
Impact of Adalimumab Withdrawal or Continuation on Severity of COVID-19 and Risk of IMID Relapse
Completed
- Conditions
- Inflammatory Bowel DiseasesRheumatic Disorder
- First Posted Date
- 2023-01-31
- Last Posted Date
- 2023-01-31
- Lead Sponsor
- IRCCS San Raffaele
- Target Recruit Count
- 49
- Registration Number
- NCT05706038
- Locations
- ๐ฎ๐น
Irccs Ospedale San Raffaele, Milano, Italy
ยฉ Copyright 2025. All Rights Reserved by MedPath